| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd. | Director | ordinary shares | 2,000 | $39,560 | $19.78 | 26 Nov 2025 | Direct |
| Eledon Pharmaceuticals, Inc. | Director | Common Stock | 3,430 | $5,179 | $1.51 | 10 Jan 2026 | Direct |
| UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10,000 | 26 Aug 2025 | Direct | ||
| UroGen Pharma Ltd. | Director | Restricted Stock Unit | 6,000 | 26 Nov 2025 | Direct | ||
| APPLIED GENETIC TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 0 | 30 Nov 2022 | Direct | ||
| Eledon Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | 10 Jan 2026 | Direct |